Search

Search Constraints

You searched for: Author/Creator Intini, Rossana

Search Results

1. The role of tumor angiogenesis as a therapeutic target in colorectal cancer. Issue 3 (4th March 2018)

2. Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. (January 2022)

3. Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?. (17th August 2018)

4. Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. Issue 4 (13th April 2021)

5. Immunotherapy in Gastrointestinal Cancers. (3rd July 2017)

6. Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer. (September 2022)

7. Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. (22nd January 2020)

8. The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. (June 2021)

9. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study. (September 2019)